Home/Filings/4/0000950170-24-077481
4//SEC Filing

Sermon Charles 4

Accession 0000950170-24-077481

CIK 0001719714other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 6:14 PM ET

Size

7.5 KB

Accession

0000950170-24-077481

Insider Transaction Report

Form 4
Period: 2024-06-21
Sermon Charles
General Counsel
Transactions
  • Exercise/Conversion

    American Depositary Shares representing Ordinary Shares

    2024-06-21+98,400230,776 total
  • Exercise/Conversion

    Performance Based Restricted Stock Unit

    2024-06-21+98,40065,600 total
    Exercise: $0.00From: 2024-06-21Exp: 2025-01-25American Depository Shares (98,400 underlying)
Footnotes (3)
  • [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
  • [F2]Represents performance-based restricted stock unit ("PSU") earned under the issuer's 2019 Employee Incentive Plan (the "Plan") that vested on June 21, 2024 based on satisfaction of ADS price threshold values over a two year performance period (expiring on January 1, 2025).
  • [F3]Reporting Person also beneficially owns 4 ordinary shares, nominal value of GBP 0.003 per ordinary share, of the Issuer.

Documents

1 file

Issuer

Mereo BioPharma Group plc

CIK 0001719714

Entity typeother

Related Parties

1
  • filerCIK 0001687318

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:14 PM ET
Size
7.5 KB